Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Racial Impact on Cytogenetic Variations and Outcome in Chronic Lymphocytic Leukemia Patients

Yaser Alkhatib, MD, Shahzaib Nabi, MD, Edward Peres, MD

Blood (2016) 128 (22): 3209.

https://doi.org/10.1182/blood.V128.22.3209.3209

Published: 2016

Journal Articles

Outcomes of Hematopoietic Stem Cell Transplant in Older Patients with Myelodysplastic Syndrome and Co-Existing Myelofibrosis: A Single Center Experience and Review of the Literature

Abhijit B Saste, Philip Kuriakose, MD, Nalini Janakiraman, MD, Edward Peres, MD, Shatha Y. Farhan, MD

Blood (2016) 128 (22): 5850.

https://doi.org/10.1182/blood.V128.22.5850.5850

Published: 2016

Journal Articles

Cytomegalovirus and Effect on Early Chimerism in Patients with Myeloid Disorders Undergoing Stem Cell Transplantation Using Reduced Toxicity Ablative Conditioning Regimen

Shatha Y. Farhan, MD, George Divine, PhD, Klodiana Neme, PharmD, Danielle Pelland, Susan Wautelet, Nancy Mikulandric, PharmD, Kenneth Ruemenapp, Edward Peres, MD, Nalini Janakiraman, MD

Blood (2015) 126 (23): 5446.

https://doi.org/10.1182/blood.V126.23.5446.5446

Published: 2015

Journal Articles

Incidence of Adrenal Insufficiency in Patients with Multiple Myeloma during High Dose Chemotherapy and Autologous Stem Cell Transplant

Ahmad Hatem Mattour, MD, Shatha Farhan, MD, Nalini Janakiraman, MD, Edward Peres, MD

Blood (2014) 124 (21): 5862.

https://doi.org/10.1182/blood.V124.21.5862.5862

Published: 2014

Journal Articles

Impact of Gender: Female Related Donor Versus Male Matched Unrelated Donor on Peripheral Blood Allogeneic Stem Cell Transplant for Male Recipients

Shatha Farhan, MD, Edward Peres, MD, Danielle Pelland, Susan Wautelet, Klodiana Neme, PharmD, Nancy Mikulandric, PharmD, Kenneth Ruemenapp, Mary Ann Trapp, Sarah Szymanski, Nalini Janakiraman, MD

Blood (2014) 124 (21): 5878.

https://doi.org/10.1182/blood.V124.21.5878.5878

Published: 2014

Journal Articles

High Rates of Early Donor Chimerism in Intermediate and Poor Risk Patients Undergoing Stem Cell Transplantation Using Reduced Toxicity Ablative Conditioning Regimen Incorporating Busulfan Pharmacokinetics

Shatha Farhan, MD, Edward Peres, MD, Danielle Pelland, Susan Wautelet, Klodiana Neme, PharmD, Nancy Mikulandric, PharmD, Kenneth Ruemenapp, Mary Ann Trapp, Sarah Szymanski, Nalini Janakiraman, MD

Blood (2014) 124 (21): 3874.

https://doi.org/10.1182/blood.V124.21.3874.3874

Published: 2014

Journal Articles

Impact Of Dysplasia On Outcome Of Patients With Acute Myeloid Leukemia and Response To Allogeneic Hematopoetic Stem Cell Transplantation

Shatha Farhan, MD, Catherine Carroll, NP, Danielle Pelland, Jose Carlos Velasco, MD, Susan Wautelet, Kenneth Ruemenapp, Suseela M Janakiraman, MBBS, Philip Kuriakose, MD, Edward Peres, MD, Nalini Janakiraman, MD

Blood (2013) 122 (21): 5551.

https://doi.org/10.1182/blood.V122.21.5551.5551

Published: 2013

Journal Articles

Frequency and Impact Of Allogeneic Hematopoetic Stem Cell Transplantation and Preparative Regimen In Patients With High and Intermediate Risk Acute Myeloid Leukemia: A Single Small Center Experience

Shatha Farhan, MD, Catherine Carroll, NP, Danielle Pelland, Jose Carlos Velasco, MD, Edward Peres, MD, Suseela M Janakiraman, MBBS, Susan Wautelet, Kenneth Ruemenapp, Philip Kuriakose, MD, Nalini Janakiraman, MD

Blood (2013) 122 (21): 5550.

https://doi.org/10.1182/blood.V122.21.5550.5550

Published: 2013

Journal Articles

A Comparative Study Of The Outcome Of Isolated Chromosome 13q and Clonal Progression Detected By I-FISH Do Additional Cytogenetic Abnormalities Impact Survival In Multiple Myeloma

Edward Peres, MD, Shatha Farhan, MD, Philip Kuriakose, MD, Susan Michalowski, PhD, Alexandra Sitarik, Suseela M Janakiraman, MBBS, Sanchez Jessica, Nalini Janakiraman, MD

Blood (2013) 122 (21): 2160.

https://doi.org/10.1182/blood.V122.21.2160.2160

Published: 2013

Journal Articles

No Survival Advantage After Double Umbilical Cord Blood (UCB) Compared to Single UCB Transplant in Children with Hematological Malignancy: Results of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0501) Randomized Trial

John E. Wagner, MD, Mary Eapen, MBBS, Shelly L Carter, ScD, Paul R. Haut, MD, Edward Peres, MD, Kirk R. Schultz, MD, Jason Thompson, Donna A. Wall, MD, Joanne Kurtzberg, MD

Blood (2012) 120 (21): 359.

https://doi.org/10.1182/blood.V120.21.359.359

Published: 2012

Journal Articles

Superior Long Term Progression Free Survival of Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma Compared to Autologous Hematopoietic Stem Cell Transplantation after Identical Conditioning Regimen.

Yasser Khaled, MD, Koji Kato, MD, John E. Levine, MD, Smitha Mellacheruvu, MD, Andrzej Jakubowiak, MD, Oleg Krijanovski, MD, Edward Peres, MD, Pavan Reddy, MD, Kevin Knott, Greg Yanik, MD, James Ferrara, MD, Shin Mineishi, MD

Blood (2007) 110 (11): 3031.

https://doi.org/10.1182/blood.V110.11.3031.3031

Published: 2007

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Racial Impact on Cytogenetic Variations and Outcome in Chronic Lymphocytic Leukemia Patients

Outcomes of Hematopoietic Stem Cell Transplant in Older Patients with Myelodysplastic Syndrome and Co-Existing Myelofibrosis: A Single Center Experience and Review of the Literature

Cytomegalovirus and Effect on Early Chimerism in Patients with Myeloid Disorders Undergoing Stem Cell Transplantation Using Reduced Toxicity Ablative Conditioning Regimen

Incidence of Adrenal Insufficiency in Patients with Multiple Myeloma during High Dose Chemotherapy and Autologous Stem Cell Transplant

Impact of Gender: Female Related Donor Versus Male Matched Unrelated Donor on Peripheral Blood Allogeneic Stem Cell Transplant for Male Recipients

High Rates of Early Donor Chimerism in Intermediate and Poor Risk Patients Undergoing Stem Cell Transplantation Using Reduced Toxicity Ablative Conditioning Regimen Incorporating Busulfan Pharmacokinetics

Impact Of Dysplasia On Outcome Of Patients With Acute Myeloid Leukemia and Response To Allogeneic Hematopoetic Stem Cell Transplantation

Frequency and Impact Of Allogeneic Hematopoetic Stem Cell Transplantation and Preparative Regimen In Patients With High and Intermediate Risk Acute Myeloid Leukemia: A Single Small Center Experience

A Comparative Study Of The Outcome Of Isolated Chromosome 13q and Clonal Progression Detected By I-FISH Do Additional Cytogenetic Abnormalities Impact Survival In Multiple Myeloma

No Survival Advantage After Double Umbilical Cord Blood (UCB) Compared to Single UCB Transplant in Children with Hematological Malignancy: Results of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0501) Randomized Trial

Superior Long Term Progression Free Survival of Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma Compared to Autologous Hematopoietic Stem Cell Transplantation after Identical Conditioning Regimen.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only